Drug Detail:Sirolimus (systemic) (monograph) (Rapamune)
Drug Class:
Sirolimus Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because almost no information is available on the use of sirolimus during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
One infant was reported breastfed (extent not stated) during maternal therapy with sirolimus, tacrolimus and prednisone in unspecified dosages following a kidney-pancreas transplant. The authors who followed the mother knew of no serious side effects in the infant.[1]
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Azathioprine, Cyclosporine, Tacrolimus
References
- 1.
-
Bramham K, Chusney G, Lee J, et al. Breastfeeding and tacrolimus: Serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol. 2013;8:563–7. [PMC free article: PMC3613954] [PubMed: 23349333]
Substance Identification
Substance Name
Sirolimus
CAS Registry Number
53123-88-9
Drug Class
Breast Feeding
Lactation
Immunosuppressive Agents
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification